FOXNEWSW The Journal Editorial Report November 28, 2020
Lets talk first about astrazeneca vaccine issues. First they reported positive results but now theres real questions about whether or not that is true. Where do we stand on that . We are trying to understand the fullness of the data. The positive side, a second form of technology has demonstrated efficacy. 60 or 90 . Its really important because it validates the virus selected to be part of the vaccine. Its the same as this coronavirus platform. The question is, why would a different schedule giving a lowered dose the first dose and a higher dose for a second dose to immunize . Why would that ...